Mehdi Hamadani

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.544Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis

British Journal of Haematology(2024)10.1111/bjh.19569

Top 36%

0.544DataRank

Top 36%12 citations

Hamza Hashmi, Kwang Woo Ahn, Mariam Allbee‐Johnson, Andy I. Chen, Baldeep Wirk +12 more

Papers

Driven by 42 papers — median percentile 64. Top paper: “Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study”.

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00103-4

N/A

2.5DataRank · unranked

86 citations

Graham P. Collins, Paolo F. Caimi, Felipe Samaniego, Alexander I. Spira, Andrew Davies +13 more

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Nature Medicine(2020)10.1038/s41591-020-1081-3

N/A

0.921DataRank · unranked

464 citations

Bryon D. Johnson, Dina Schneider, Fenlu Zhu, Anikó Szabó, Carolyn A. Keever-Taylor +11 more

Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.07.018

N/A

0.677DataRank · unranked

90 citations

Tania Jain, M. Veronica Dioverti, Martina Pennisi, Lekha Mikkilineni, Swetha Kambhampati Thiruvengadam +9 more

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.027

N/A

0.581DataRank · unranked

47 citations

Mei-Jie Zhang, Xiao-Ying Tang, Stephanie J. Lee, Ming-Wei Fei, Hai-Lin Wang +14 more

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Leukemia(2021)10.1038/s41375-021-01213-5

N/A

0.564DataRank · unranked

42 citations

Wendy Stock, Anjali S. Advani, Selina M. Luger, Richard A. Larson, Martin S. Tallman +22 more

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis

British Journal of Haematology(2024)10.1111/bjh.19569

Top 36%

0.544DataRank

Top 36%12 citations

Hamza Hashmi, Kwang Woo Ahn, Mariam Allbee‐Johnson, Andy I. Chen, Baldeep Wirk +12 more

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

Cancer(2020)10.1002/cncr.32752

N/A

0.483DataRank · unranked

24 citations

Navneet S. Majhail, Yizeng He, Kwang Woo Ahn, Carlos Litovich, Sairah Ahmed +32 more

Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703

Journal of Clinical Oncology(2025)10.1200/jco.24.00921

N/A

0.330DataRank · unranked

8 citations

Javier Bolaños-Meade, Monzr M. Al Malki, Juan Wu, Carrie L. Kitko, Ran Reshef +27 more

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)

medRxiv(2024)10.1101/2024.01.24.24301058

N/A

0.165DataRank · unranked

2 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Indications and Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies in Adults

Hematology(2018)10.1016/b978-0-323-35762-3.00104-9

N/A

0.104DataRank · unranked

1 citations

Parameswaran N. Hari, Mehdi Hamadani

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.001

N/A

0DataRank · unranked

16 citations

Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling +29 more

Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.014

N/A

0DataRank · unranked

10 citations

Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Guru Subramanian Guru Murthy, Frederick L. Locke +10 more

Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2020.12.002

N/A

0DataRank · unranked

4 citations

Sherif M. Badawy, Elizabeth Suelzer, Hemant S. Murthy, Pinki Prasad, Hesham Eissa +13 more

Effect of time to relapse on overall survival (OS) in mantle cell lymphoma (MCL) patients (pts) following frontline high-dose therapy and autologous hematopoietic cell transplantation (autoHCT).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7521

N/A

0DataRank · unranked

0 citations

Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Mohamed A. Kharfan‐Dabaja, Alex F. Herrera +3 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit

Haematologica(2022)10.3324/haematol.2021.279999

N/A

0DataRank · unranked

7 citations

Mehdi Hamadani, Kwang Woo Ahn, Yue Chen, Mohamed A. Kharfan‐Dabaja, Craig S. Sauter +2 more

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.007

N/A

0DataRank · unranked

71 citations

Jianqun Kou, Min Chen, Yung‐Tsi Bolon, Larisa Broglie, Caitrin Bupp +23 more

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.101983

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +23 more

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

Haematologica(2023)10.3324/haematol.2022.282269

N/A

0DataRank · unranked

5 citations

Mei-Jei Zhang, Linda J. Burns, Xiaoying Tang, Christa L. Meyer, Lih‐Wen Mau +18 more

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Bone Marrow Transplantation(2023)10.1038/s41409-023-02110-4

N/A

0DataRank · unranked

3 citations

Mehdi Hamadani, Michael J. Martens, Haris Ali, Patrice Chevallier, Hannah Choe +20 more

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.013

N/A

0DataRank · unranked

707 citations

Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra +16 more

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2024013863

N/A

0DataRank · unranked

21 citations

Joshua Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan +14 more

CNS manifestations in acute and chronic graft-versus-host disease

Brain(2024)10.1093/brain/awae340

N/A

0DataRank · unranked

19 citations

Florence Forte, Majdouline El Moussaoui, Justine Monseur, Nicole Raus, A. Yu. Polushin +42 more

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.05.022

N/A

0DataRank · unranked

3 citations

William Wesson, Emerson Logan, Carine Tabak, Muhammad Umair Mushtaq, Tara L. Lin +7 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS

British Journal of Haematology(2025)10.1111/bjh.70020

N/A

0DataRank · unranked

2 citations

Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid, Ahmed Al Nughmush +18 more

Accurate prediction of absolute prokaryotic abundance from DNA concentration

Cell Reports Methods(2025)10.1016/j.crmeth.2025.101030

N/A

0DataRank · unranked

2 citations

Tessa M. Andermann, Erin F. Brooks, Lanya Evans, Adam Groth, Mai Dvorak +23 more

CD19 directed CAR T therapy for intravascular large B-cell lymphoma

Haematologica(2025)10.3324/haematol.2025.288838

N/A

0DataRank · unranked

1 citations

Ajay K. Gopal, Hannah Cherniawsky, Ron Ram, Rammurti T. Kamble, Mehdi Hamadani +1 more

143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)

Hematological Oncology(2025)10.1002/hon.70093_143

N/A

0DataRank · unranked

1 citations

Constance Lau, Mazyar Shadman, Alex F. Herrera, Caron A. Jacobson, F. L. Locke +13 more

Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory (R/R) secondary central nervous system lymphoma (SCNSL).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7024

N/A

0DataRank · unranked

0 citations

Babatunde Adedokun, Hamza Hashmi, Mazyar Shadman, Allison Winter, Alex F. Herrera +14 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1

N/A

0DataRank · unranked

0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae291

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266

N/A

0DataRank · unranked

36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Blood Advances(2020)10.1182/bloodadvances.2019000765

N/A

0DataRank · unranked

51 citations

J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza +9 more

Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy

Transplantation and Cellular Therapy(2020)10.1016/j.bbmt.2020.09.004

N/A

0DataRank · unranked

18 citations

Luciano J. Costa, Craig S. Sauter, Carlos Litovich, Mehdi Hamadani, Susan Bal

Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Journal of the National Comprehensive Cancer Network(2020)10.6004/jnccn.2020.7559

N/A

0DataRank · unranked

29 citations

Miguel‐Angel Perales, Mehdi Hamadani, Abraham S. Kanate

Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation

Transplantation and Cellular Therapy(2020)10.1016/j.bbmt.2020.09.014

N/A

0DataRank · unranked

28 citations

Kwang Woo Ahn, Manoj Khanal, Carlos Litovich, Sairah Ahmed, Nilanjan Ghosh +5 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Blood Advances(2021)10.1182/bloodadvances.2021004865

N/A

0DataRank · unranked

54 citations

Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir +25 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

JCO Precision Oncology(2021)10.1200/po.20.00355

N/A

0DataRank · unranked

25 citations

Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li +17 more

Mehdi Hamadani

Indexed papers

Top data-sharing exemplar

Papers